CNTA
Price
$13.61
Change
+$0.58 (+4.45%)
Updated
Apr 24 closing price
Capitalization
1.81B
24 days until earnings call
KYMR
Price
$33.56
Change
+$2.86 (+9.32%)
Updated
Apr 24 closing price
Capitalization
2.18B
6 days until earnings call
Ad is loading...

CNTA vs KYMR

Header iconCNTA vs KYMR Comparison
Open Charts CNTA vs KYMRBanner chart's image
Centessa Pharmaceuticals
Price$13.61
Change+$0.58 (+4.45%)
Volume$538.96K
Capitalization1.81B
Kymera Therapeutics
Price$33.56
Change+$2.86 (+9.32%)
Volume$1.3M
Capitalization2.18B
CNTA vs KYMR Comparison Chart
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. KYMR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a StrongBuy and KYMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CNTA: $13.61 vs. KYMR: $33.56)
Brand notoriety: CNTA and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 52% vs. KYMR: 165%
Market capitalization -- CNTA: $1.81B vs. KYMR: $2.18B
CNTA [@Biotechnology] is valued at $1.81B. KYMR’s [@Biotechnology] market capitalization is $2.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than CNTA.

Price Growth

CNTA (@Biotechnology) experienced а +10.70% price change this week, while KYMR (@Biotechnology) price change was +29.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

CNTA is expected to report earnings on Aug 18, 2025.

KYMR is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.18B) has a higher market cap than CNTA($1.81B). KYMR YTD gains are higher at: -16.580 vs. CNTA (-18.746). CNTA has higher annual earnings (EBITDA): -147.19M vs. KYMR (-216.24M). CNTA has more cash in the bank: 518M vs. KYMR (489M). CNTA (84.7M) and KYMR (87.8M) have identical debt. KYMR has higher revenues than CNTA: KYMR (47.1M) vs CNTA (6.85M).
CNTAKYMRCNTA / KYMR
Capitalization1.81B2.18B83%
EBITDA-147.19M-216.24M68%
Gain YTD-18.746-16.580113%
P/E RatioN/AN/A-
Revenue6.85M47.1M15%
Total Cash518M489M106%
Total Debt84.7M87.8M96%
TECHNICAL ANALYSIS
Technical Analysis
CNTAKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFEBX47.53N/A
N/A
MFS Value B
MVSSX26.88N/A
N/A
Victory Integrity Small-Cap Value R6
JGRQX14.92N/A
N/A
JPMorgan Small Cap Growth R3
AVDNX12.72N/A
N/A
Avantis® International Equity G
SHXIX12.44N/A
N/A
American Beacon Shapiro Equity Opps R5

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with XENE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
+4.45%
XENE - CNTA
43%
Loosely correlated
+1.62%
KYMR - CNTA
42%
Loosely correlated
+9.32%
ORIC - CNTA
42%
Loosely correlated
+0.39%
CRNX - CNTA
42%
Loosely correlated
+3.15%
BNTX - CNTA
41%
Loosely correlated
+4.97%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+9.32%
CCCC - KYMR
63%
Loosely correlated
N/A
NRIX - KYMR
56%
Loosely correlated
-0.78%
RVMD - KYMR
55%
Loosely correlated
+3.04%
IMNM - KYMR
55%
Loosely correlated
+0.24%
RCKT - KYMR
54%
Loosely correlated
+4.06%
More